168 related articles for article (PubMed ID: 34438383)
1. Simulated dose painting of hypoxic sub-volumes in pancreatic cancer stereotactic body radiotherapy.
Elamir AM; Stanescu T; Shessel A; Tadic T; Yeung I; Letourneau D; Kim J; Lukovic J; Dawson LA; Wong R; Barry A; Brierley J; Gallinger S; Knox J; O'Kane G; Dhani N; Hosni A; Taylor E
Phys Med Biol; 2021 Sep; 66(18):. PubMed ID: 34438383
[TBL] [Abstract][Full Text] [Related]
2. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
[TBL] [Abstract][Full Text] [Related]
3. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes.
Even AJ; van der Stoep J; Zegers CM; Reymen B; Troost EG; Lambin P; van Elmpt W
Radiother Oncol; 2015 Aug; 116(2):281-6. PubMed ID: 26238010
[TBL] [Abstract][Full Text] [Related]
4. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.
Lin Z; Mechalakos J; Nehmeh S; Schoder H; Lee N; Humm J; Ling CC
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1219-28. PubMed ID: 18313529
[TBL] [Abstract][Full Text] [Related]
5. Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.
Wang S; Zheng D; Lin C; Lei Y; Verma V; Smith A; Ma R; Enke CA; Zhou S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819851520. PubMed ID: 31195891
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.
Grosu AL; Souvatzoglou M; Röper B; Dobritz M; Wiedenmann N; Jacob V; Wester HJ; Reischl G; Machulla HJ; Schwaiger M; Molls M; Piert M
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):541-51. PubMed ID: 17869667
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study.
Chang JH; Wada M; Anderson NJ; Lim Joon D; Lee ST; Gong SJ; Gunawardana DH; Sachinidis J; O'Keefe G; Gan HK; Khoo V; Scott AM
Acta Oncol; 2013 Nov; 52(8):1723-9. PubMed ID: 23317145
[TBL] [Abstract][Full Text] [Related]
8.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
9. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation.
Kjellsson Lindblom E; Ureba A; Dasu A; Wersäll P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I
Med Phys; 2019 May; 46(5):2512-2521. PubMed ID: 30924937
[TBL] [Abstract][Full Text] [Related]
10. Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model.
Nakamura A; Prichard HA; Wo JY; Wolfgang JA; Hong TS
J Appl Clin Med Phys; 2019 Feb; 20(2):71-83. PubMed ID: 30636367
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
12. Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.
Arnesen MR; Rekstad BL; Stokke C; Bruheim K; Løndalen AM; Hellebust TP; Malinen E
Radiat Oncol; 2016 Mar; 11():39. PubMed ID: 26968827
[TBL] [Abstract][Full Text] [Related]
13. Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study.
Clausen MM; Hansen AE; Lundemann M; Hollensen C; Pommer T; Munck Af Rosenschöld P; Kristensen AT; Kjær A; McEvoy FJ; Engelholm SA
Radiat Oncol; 2014 Oct; 9():228. PubMed ID: 25319766
[TBL] [Abstract][Full Text] [Related]
14. Photon and Proton Dose Painting Based on Oxygen Distribution - Feasibility Study and Tumour Control Probability Assessment.
Ureba A; Ödén J; Toma-Dasu I; Lazzeroni M
Adv Exp Med Biol; 2022; 1395():223-228. PubMed ID: 36527641
[TBL] [Abstract][Full Text] [Related]
15. Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images.
Young T; Lee M; Johnston M; Nguyen T; Ko R; Arumugam S
Phys Eng Sci Med; 2023 Dec; 46(4):1619-1627. PubMed ID: 37747645
[TBL] [Abstract][Full Text] [Related]
16. Validation of dose painting of lung tumours using alanine/EPR dosimetry.
Knudtsen IS; Svestad JG; Skaug Sande EP; Rekstad BL; Rødal J; van Elmpt W; Öllers M; Hole EO; Malinen E
Phys Med Biol; 2016 Mar; 61(6):2243-54. PubMed ID: 26913997
[TBL] [Abstract][Full Text] [Related]
17. Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[
Kosztyla R; Raman S; Moiseenko V; Reinsberg SA; Toyota B; Nichol A
Br J Radiol; 2019 Jul; 92(1099):20180901. PubMed ID: 31017449
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia imaging with [18F]-FMISO-PET for guided dose escalation with intensity-modulated radiotherapy in head-and-neck cancers.
Henriques de Figueiredo B; Zacharatou C; Galland-Girodet S; Benech J; De Clermont-Gallerande H; Lamare F; Hatt M; Digue L; De Mones del Pujol E; Fernandez P
Strahlenther Onkol; 2015 Mar; 191(3):217-24. PubMed ID: 25245468
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of
Berwouts D; Madani I; Duprez F; Olteanu AL; Vercauteren T; Boterberg T; Deron P; Bonte K; Huvenne W; De Neve W; Goethals I
Head Neck; 2017 Nov; 39(11):2264-2275. PubMed ID: 28833829
[TBL] [Abstract][Full Text] [Related]
20. Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation Therapy.
Feng Z; Rao AD; Cheng Z; Shin EJ; Moore J; Su L; Kim SH; Wong J; Narang A; Herman JM; McNutt T; Li D; Ding K
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):651-659. PubMed ID: 30031143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]